Dry artificial lung surfactant and its effect on very premature babies

Lancet. 1981 Jan 10;1(8211):64-8. doi: 10.1016/s0140-6736(81)90002-7.

Abstract

Artificial lung surfactant prepared with pure dipalmitoylphosphatidylcholine and phosphatidylglycerol in a ratio of 7:3 was made as a dry powder and then blown down an endotracheal tube into the lungs of 22 very premature babies at birth. Only one dose was given. The treated babies did better than their 33 controls. Fewer needed ventilation, and those who did required lower pressures in the first six hours of life. None of the treated babies died, compared with 8 of the controls.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials as Topic
  • Female
  • Humans
  • Infant, Newborn
  • Lung Compliance / drug effects
  • Male
  • Pulmonary Surfactants / administration & dosage
  • Pulmonary Surfactants / chemical synthesis
  • Pulmonary Surfactants / therapeutic use*
  • Respiratory Distress Syndrome, Newborn / mortality
  • Respiratory Distress Syndrome, Newborn / prevention & control*
  • Risk

Substances

  • Pulmonary Surfactants